Table 4.
Trends of bacterial isolates among paediatric and adult populations, n=(471).
| Bacterial isolates | Number (%) | Paediatric patients (n = 130) | Adult patients (n = 341) | p value | ||
|---|---|---|---|---|---|---|
| 2016 (n=75) | 2017 (n=55) | 2016 (n=164) | 2017 (n=177) | |||
| Gram-positive isolates | 338 (71.8%) | 61 (81.3) | 46 (83.6) | 122 (74.4) | 109 (61.6) | |
| Streptococcus spp. | 23 (4.9) | 8 (10.7) | 5 (9.1) | 6 (3.7) | 4 (2.3) | 0.940 |
| Coagulase-negative Staphylococcus (CoNS) | 246 (52.2) | 49 (65.3) | 35 (63.6) | 79 (48.2) | 83 (46.9) | 0.154 |
| Staphylococcus aureus | 62 (13.2) | 3 (4.0) | 6 (10.9) | 35 (21.3) | 18 (10.2) | 0.063 |
| Enterococcus spp. | 7 (1.5) | 1 (1.3) | 0 (0.0) | 2 (1.2) | 4 (2.3) | 0.212 |
| Gram-negative isolates | 133 (28.2) | 14 (18.7) | 9 (16.4) | 42 (25.6) | 68 (38.4) | |
| Klebsiella spp. | 63 (13.4) | 6 (8.0) | 6 (10.9) | 19 (11.6) | 32 (18.1) | 0.417 |
| Acinetobacter spp. | 7 (1.5) | 4 (5.3) | 3 (5.5) | 4 (2.4) | 3 (1.7) | — |
| Pseudomonas aeruginosa | 5 (1.1) | 1 (1.3) | 0 (0.0) | 2 (1.2) | 2 (1.1) | 0.361 |
| Pseudomonas spp. | 12 (2.5) | 3 (4.0) | 1 (1.8) | 1 (0.6) | 7 (4.0) | 0.030 |
| Escherichia coli | 42 (8.9) | 3 (4.0) | 1 (1.8) | 14 (8.5) | 24 (13.6) | 0.139 |
| Salmonella spp. | 4 (0.8) | 1 (1.3) | 1 (1.8) | 2 (1.2) | 0 (0.0) | 0.248 |